Optimising biomarkers for accurate ependymoma diagnosis, prognostication and stratification within International Clinical Trials: A BIOMECA study

Optimising biomarkers for accurate ependymoma diagnosis, prognostication and stratification within International Clinical Trials: A BIOMECA study

ABSTRACT Background Accurate identification of brain tumour molecular subgroups is increasingly important. We aimed to establish the most accurate and reproducible ependymoma subgroup biomarker detection techniques, across 147 cases from International Society of Pediatric Oncology (SIOP) Ependymoma...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebecca Chapman, David R. Ghasemi, Felipe Andreiuolo, Valentina Zschernack, Arnault Tauziede Espariat, Francesca Romana Buttarelli, Felice Giangaspero, Jacques Grill, Christine Haberler, Simon Paine, Ian C. Scott, Thomas S. Jacques, Martin Sill, Stefan M. Pfister, John‐Paul Kilday, Pierre Leblond, Maura Massimino, Hendrik Witt, Piergiorgio Modena, Pascale Varlet, Torsten Pietsch, Richard G. Grundy, Kristian W. Pajtler, Timothy Ritzmann
Format: Pré-impressão
Language:English
Published: 2022
Online Access:https://doi.org/10.1101/2022.11.24.22282659
https://www.medrxiv.org/content/medrxiv/early/2022/11/29/2022.11.24.22282659.full.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1101/2022.11.24.22282659
https://www.medrxiv.org/content/medrxiv/early/2022/11/29/2022.11.24.22282659.full.pdf

Similar Items